Sepracor

Executive Summary

Has two different single-isomer versions of fluoxetine (Eli Lilly's Prozac) in preclinicals for depression and migraine indications. Speaking Nov. 19 at the Robertson Stephens medical conference, Sepracor President Timothy Barberich said that the company's R-fluoxetine, which has a much shorter half-life than the racemic version, may not exhibit the side effects exhibited by regular fluoxetine when used to treat migraine. In the Nov. 25 issue of "The Pink Sheet," it was reported that Barberich made this claim about the Sepracor's S-fluoxetine for depression.